Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Glycemic improvements similar with omarigliptin and sitagliptin in patients with type 2 diabetes

Sep. 22, 2015

New biomarkers described for liver transplant

Sep. 21, 2015

First clinical results disclosed for Enanta's EDP-239

Sep. 21, 2015

Beta-lactamase inhibitor CB-618 pharmacokinetics-pharmacodynamics characterized with other agents

Sep. 21, 2015

Soluble Nogo-B improves angiogenesis in vitro

Sep. 21, 2015

Novel MAb treats diabetes and fatty liver disease in obesity models

Sep. 21, 2015

Hypoglycemia may be detected by analyzing exhaled breath

Sep. 18, 2015

Phase I/IIa results presented for ChAd-EBO-Z Ebola vaccine

Sep. 18, 2015

Prolyl oligopeptidase inhibitor shows promise for cognitive deficit associated with schizophrenia

Sep. 18, 2015

Proof-of-concept study shows promise of novel antimalarial KAF-156

Sep. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...